Gastroenterology
The ability to transfer resistance to infection suggests that the microbiota could be harnessed for therapeutic treatments. A new study published in Cell Reports claims.
A study published in Nature Medicine claims that the manipulation of the gut microbiota could be a new strategy to treat toxicity to combined immunotherapy.
Fecal microbiota transplants combined with daily fiber supplement improves insulin sensitivity in obese individuals with metabolic syndrome.
A new study published in Cell Host & Microbe illustrates how different dispersal strategies can allow bacteria to persist in the human gut.
A high-fat diet is associated with changes in the gut microbiota and microbial metabolites. These changes seem impair antibiotic efficacy.
A new study published in Cell could help to detect infection outbreaks and study the distribution of antibiotic-resistant microbes in different urban areas.
Specific food dyes are environmental risk factors for colitis development in conditions where IL-23 expression is dysregulated.
A new study published in Cell Host & Microbe could pave the way for using phages as biomarkers for the condition of rheumatoid arthritis.
The alterations in gut microbiota composition observed in mice lacking TAK1 can generate a protective immunity against colitis and colorectal cancer.
Fatty acid amides produced by Clostridia can help the bacteria to modulate their host by mimicking human signaling molecules.
